Perbak Capital Partners’s Hinge Health HNGE Stock Holding History
Bought
Maintained
Sold
Other funds holding HNGE
IHG
12CM
DMC
BC
RI
ACH
B
VPM
Perbak Capital Partners's HNGE Position: Q1 2026 in Review
Perbak Capital Partners increased its Hinge Health (HNGE) stake by 6.9% in Q1 2026, buying an estimated $19K and bringing the position to 7,138 shares worth $275K. The position accounts for 0.07% of the portfolio, ranked #265.
Perbak Capital Partners first reported a position in HNGE in Q3 2025 and has held it in 3 quarters since. The position peaked at $746K in Q3 2025. 203 funds tracked by Wall St. Rank hold HNGE as of Q1 2026.
- Perbak Capital Partners held 7,138 shares of Hinge Health worth $275K as of Q1 2026.
- Perbak Capital Partners bought 458 Hinge Health shares in Q1 2026, an estimated $19K.
- Hinge Health made up 0.07% of Perbak Capital Partners's portfolio in Q1 2026, its #265 holding.
- Perbak Capital Partners first reported a position in Hinge Health in Q3 2025 and has held it in 3 quarters since.
- Perbak Capital Partners's Hinge Health position peaked at $746K in Q3 2025.
- 203 funds tracked by Wall St. Rank held Hinge Health as of Q1 2026.
Based on Perbak Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.